Anti-inflammatory (Colchicine) Treatment for Secondary Prevention in Coronary Artery Disease: A Milestone has Been Met-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-inflammatory (Colchicine) Treatment for Secondary Prevention in Coronary Artery Disease: A Milestone has Been Met

Published:2023-10 Issue:4 Volume:82 Page:237-240
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Moroni Francesco¹²,Abbate Antonio¹

Affiliation:

1. Division of Cardiology and Berne Cardiovascular Research Center, Heart and Vascular Center, School of Medicine, University of Virginia, Charlottesville, VA

2. Division of Cardiology, Department of Cardiovascular Sciences, Università Milano-Bicocca, Milan, Italy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference14 articles.

1. Inflammation and atherosclerosis;Libby;Circulation,2002

2. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease;Abbate;Circ Res,2020

3. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study;Albert;ACC Curr J Rev,2001

4. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N Engl J Med,2017

5. Mechanism of action of colchicine in the treatment of gout;Dalbeth;Clin Ther,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP